4.5 Article

The presence and severity of epilepsy coincide with reduced γ-aminobutyrate and cortical excitatory markers in succinic semialdehyde dehydrogenase deficiency

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Understanding the Molecular Mechanisms of Succinic Semialdehyde Dehydrogenase Deficiency (SSADHD): Towards the Development of SSADH-Targeted Medicine

Henry H. C. Lee et al.

Summary: Succinic semialdehyde dehydrogenase deficiency (SSADHD) is a rare genetic disorder that leads to incomplete metabolism of the neurotransmitter GABA, resulting in various clinical manifestations. This article reviews relevant molecular mechanisms and discusses the challenges in SSADHD gene and enzyme replacement therapies. It also introduces a mouse model that restores SSADH activity.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Clinical Neurology

Succinic Semialdehyde Dehydrogenase Deficiency: Review of the Natural History Study

Phillip L. Pearl et al.

Summary: The SSADHD Natural History Study aims to define the natural course of the disorder and identify biomarkers correlating with severity. At the halfway point, 28 subjects have been recruited, showing increasing incidence and severity of epilepsy and psychiatric symptoms in adolescence and adulthood. The study also found abnormal brain waves, with reduced gamma frequency band consistent with GABAergic dysfunction.

JOURNAL OF CHILD NEUROLOGY (2021)

Article Clinical Neurology

Magnetic Resonance Imaging (MRI) and Spectroscopy in Succinic Semialdehyde Dehydrogenase Deficiency

Onur Afacan et al.

Summary: In this study, advanced MR spectroscopy techniques were used to show significant increases in brain GABA concentrations in SSADH deficiency patients, with structural MRI revealing signal hyperintensities in the globus pallidus and cerebellar dentate nucleus.

JOURNAL OF CHILD NEUROLOGY (2021)

Article Clinical Neurology

Enzyme Replacement Therapy for Succinic Semialdehyde Dehydrogenase Deficiency: Relevance in γ-Aminobutyric Acid Plasticity

Henry Hing Cheong Lee et al.

Summary: SSADHD is a rare metabolic disorder caused by functional impairment of the SSADH enzyme, leading to accumulation of GABA and GHB in the brain, resulting in various neurological symptoms. Research is focusing on safely and feasibly restoring SSADH enzyme through enzyme replacement therapy or gene therapy to treat SSADHD patients.

JOURNAL OF CHILD NEUROLOGY (2021)

Review Cell Biology

Succinic Semialdehyde Dehydrogenase Deficiency: An Update

Miroslava Didiasova et al.

Review Pharmacology & Pharmacy

Review of Transcranial Magnetic Stimulation in Epilepsy

Melissa Tsuboyama et al.

CLINICAL THERAPEUTICS (2020)

Review Behavioral Sciences

Biomarkers Obtained by Transcranial Magnetic Stimulation of the Motor Cortex in Epilepsy

Melissa Tsuboyama et al.

FRONTIERS IN INTEGRATIVE NEUROSCIENCE (2019)

Article Clinical Neurology

Age-related phenotype and biomarker changes in SSADH deficiency

Melissa L. DiBacco et al.

ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2019)

Article Clinical Neurology

Gamma-aminobutyric acid levels in cerebrospinal fluid in neuropaediatric disorders

Elisenda Cortes-Saladelafont et al.

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2018)

Review Clinical Neurology

Inherited disorders of gamma-aminobutyric acid metabolism and advances in ALDH5A1 mutation identification

Phillip L. Pearl et al.

DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY (2015)

Article Pediatrics

Disorders of GABA metabolism: SSADH and GABA-transaminase deficiencies

Mahsa Parviz et al.

JOURNAL OF PEDIATRIC EPILEPSY (2014)

Article Endocrinology & Metabolism

Thirty years beyond discovery-Clinical trials in succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism

Kara R. Vogel et al.

JOURNAL OF INHERITED METABOLIC DISEASE (2013)

Article Clinical Neurology

GABAB-ergic motor cortex dysfunction in SSADH deficiency

Janine Reis et al.

NEUROLOGY (2012)

Article Clinical Neurology

Epilepsy in succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism

Phillip L. Pearl et al.

BRAIN & DEVELOPMENT (2011)

Article Clinical Neurology

Neuropathology in Succinic Semialdehyde Dehydrogenase Deficiency

Ina Knerr et al.

PEDIATRIC NEUROLOGY (2010)

Article Endocrinology & Metabolism

Succinic semialdehyde dehydrogenase deficiency: Lessons from mice and men

P. L. Pearl et al.

JOURNAL OF INHERITED METABOLIC DISEASE (2009)

Review Pharmacology & Pharmacy

Behavioral analyses of GHB: Receptor mechanisms

Lawrence P. Carter et al.

PHARMACOLOGY & THERAPEUTICS (2009)

Review Clinical Neurology

MOLECULAR PATHOLOGY OF GENETIC EPILEPSIES ASSOCIATED WITH GABA(A) RECEPTOR SUBUNIT MUTATIONS

Robert L. Macdonald et al.

EPILEPSY CURRENTS (2009)

Article Biochemistry & Molecular Biology

Increased guanidino species in murine and human succinate semialdehyde dehydrogenase (SSADH) deficiency

EEW Jansen et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2006)

Article Mathematical & Computational Biology

Estimation of the Youden index and its associated cutoff point

R Fluss et al.

BIOMETRICAL JOURNAL (2005)

Review Physiology

Molecular structure and physiological functions of GABAB receptors

B Bettler et al.

PHYSIOLOGICAL REVIEWS (2004)

Article Behavioral Sciences

Absence seizures in succinic semialdehyde dehydrogenase deficient mice: a model of juvenile absence epilepsy

MA Cortez et al.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2004)

Article Biochemical Research Methods

Effect of valproic acid on the urinary metabolic profile of a patient with succinic semialdehyde dehydrogenase deficiency

T Shinka et al.

JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES (2003)

Review Clinical Neurology

Clinical spectrum of succinic semialdehyde dehydrogenase deficiency

PL Pearl et al.

NEUROLOGY (2003)

Article Clinical Neurology

Murine succinate semialdehyde dehydrogenase deficiency

M Gupta et al.

ANNALS OF NEUROLOGY (2003)